Ling et al. demonstrated that, when compared with non-atopic controls, CD4+CD25+ cells of atopic patients have an impaired ability to suppress proliferation and IL-5 release by CD4+CD25-T cells, particularly in patients with hay fever assessed during the pollen season [56]. This evidence concerns the gene IL2RA and seasonal allergic rhinitis.